| AG-AZITHROMYCIN (250 MG)Angita Pharma Inc. · Status since Sep 2018 | 02480700 | Marketed | Angita Pharma Inc. | Sep 2018 |
| APO-AZITHROMYCIN Z (250 MG)Apotex Inc. · Status since Mar 2014 | 02415542 | Marketed | Apotex Inc. | Mar 2014 |
| AURO-AZITHROMYCIN (100 MG)Auro Pharma Inc. · Status since Oct 2019 | 02482363 | Marketed | Auro Pharma Inc. | Oct 2019 |
| AURO-AZITHROMYCIN (200 MG)Auro Pharma Inc. · Status since Oct 2019 | 02482371 | Marketed | Auro Pharma Inc. | Oct 2019 |
| AZITHROMYCIN (250 MG)Sanis Health Inc. · Status since Aug 2017 | 02330881 | Marketed | Sanis Health Inc. | Aug 2017 |
| AZITHROMYCIN (250 MG)Sivem Pharmaceuticals Ulc · Status since Jan 2018 | 02442434 | Marketed | Sivem Pharmaceuticals Ulc | Jan 2018 |
| AZITHROMYCIN (250 MG)10445517 Canada Inc · Status since Feb 2025 | 02545969 | Marketed | 10445517 Canada Inc | Feb 2025 |
| AZITHROMYCIN FOR INJECTION (500 MG)JAMP Pharma Corporation · Status since May 2022 | 02523825 | Marketed | JAMP Pharma Corporation | May 2022 |
| AZITHROMYCIN FOR INJECTION (500 MG)Generic Medical Partners Inc · Status since Mar 2023 | 02524449 | Marketed | Generic Medical Partners Inc | Mar 2023 |
| AZITHROMYCIN FOR INJECTION USP (500 MG)Sterimax Inc. · Status since Apr 2019 | 02483890 | Marketed | Sterimax Inc. | Apr 2019 |
| AZITHROMYCIN FOR INJECTION, USP (500 MG)Auro Pharma Inc. · Status since Oct 2017 | 02465604 | Marketed | Auro Pharma Inc. | Oct 2017 |
| AZITHROMYCIN FOR INJECTION, USP (500 MG)Eugia Pharma Inc. · Status since Oct 2024 | 02531429 | Marketed | Eugia Pharma Inc. | Oct 2024 |
| JAMP-AZITHROMYCIN (250 MG)JAMP Pharma Corporation · Status since Sep 2016 | 02452308 | Marketed | JAMP Pharma Corporation | Sep 2016 |
| M-AZITHROMYCIN (250 MG)Mantra Pharma Inc. · Status since Jan 2021 | 02502038 | Marketed | Mantra Pharma Inc. | Jan 2021 |
| MAR-AZITHROMYCIN (250 MG)Marcan Pharmaceuticals Inc. · Status since Mar 2023 | 02452324 | Marketed | Marcan Pharmaceuticals Inc. | Mar 2023 |
| NRA-AZITHROMYCIN (250 MG)Nora Pharma Inc. · Status since May 2019 | 02479680 | Marketed | Nora Pharma Inc. | May 2019 |
| PMS-AZITHROMYCIN (250 MG)Pharmascience Inc. · Status since Jan 2006 | 02261634 | Marketed | Pharmascience Inc. | Jan 2006 |
| PRO-AZITHROMYCINE (250 MG)Pro Doc Limitee · Status since Sep 2026 | 02310600 | Marketed | Pro Doc Limitee | Sep 2026 |
| RIVA-AZITHROMYCIN (250 MG)Laboratoire Riva Inc. · Status since Jun 2024 | 02275309 | Marketed | Laboratoire Riva Inc. | Jun 2024 |
| SANDOZ AZITHROMYCIN (250 MG)Sandoz Canada Inc. · Status since Mar 2016 | 02265826 | Marketed | Sandoz Canada Inc. | Mar 2016 |
| SANDOZ AZITHROMYCIN (100 MG)Sandoz Canada Inc. · Status since Oct 2021 | 02332388 | Marketed | Sandoz Canada Inc. | Oct 2021 |
| SANDOZ AZITHROMYCIN (200 MG)Sandoz Canada Inc. · Status since Oct 2021 | 02332396 | Marketed | Sandoz Canada Inc. | Oct 2021 |
| AG-AZITHROMYCIN (600 MG)Angita Pharma Inc. · Status since Jul 2022 | 02480719 | Dormant | Angita Pharma Inc. | Jul 2022 |
| ALTA-AZITHROMYCIN (250 MG)Altamed Pharma · Status since May 2026 | 02477610 | Approved | Altamed Pharma | May 2026 |
| AZITHROMYCIN (600 MG)10445517 Canada Inc · Status since Mar 2024 | 02545977 | Approved | 10445517 Canada Inc | Mar 2024 |
| AZITHROMYCIN FOR INJECTION (500 MG)Sterimax Inc. · Status since Jul 2020 | 02368846 | Dormant | Sterimax Inc. | Jul 2020 |
| AZITHROMYCIN FOR INJECTION, USP (500 MG)Strides Pharma Canada Inc · Status since Aug 2021 | 02358816 | Approved | Strides Pharma Canada Inc | Aug 2021 |
| BIO-AZITHROMYCIN (250 MG)Biomed Pharma · Status since Apr 2026 | 02567881 | Approved | Biomed Pharma | Apr 2026 |
| BIO-AZITHROMYCIN (600 MG)Biomed Pharma · Status since Apr 2026 | 02567903 | Approved | Biomed Pharma | Apr 2026 |
| IPG-AZITHROMYCIN (250 MG)Marcan Pharmaceuticals Inc. · Status since Jul 2016 | 02446359 | Approved | Marcan Pharmaceuticals Inc. | Jul 2016 |
| IPG-AZITHROMYCIN (600 MG)Marcan Pharmaceuticals Inc. · Status since Jul 2016 | 02446367 | Approved | Marcan Pharmaceuticals Inc. | Jul 2016 |
| JAMP-AZITHROMYCIN (600 MG)JAMP Pharma Corporation · Status since Apr 2016 | 02452316 | Approved | JAMP Pharma Corporation | Apr 2016 |
| M-AZITHROMYCIN (600 MG)Mantra Pharma Inc. · Status since Jul 2020 | 02502046 | Approved | Mantra Pharma Inc. | Jul 2020 |
| MAR-AZITHROMYCIN (600 MG)Marcan Pharmaceuticals Inc. · Status since Sep 2016 | 02452332 | Approved | Marcan Pharmaceuticals Inc. | Sep 2016 |
| NRA-AZITHROMYCIN (600 MG)Nora Pharma Inc. · Status since Aug 2018 | 02479699 | Approved | Nora Pharma Inc. | Aug 2018 |
| PMS-AZITHROMYCIN (600 MG)Pharmascience Inc. · Status since Jul 2026 | 02261642 | Dormant | Pharmascience Inc. | Jul 2026 |
| PRO-AZITHROMYCINE (600 MG)Pro Doc Limitee · Status since Nov 2025 | 02562944 | Approved | Pro Doc Limitee | Nov 2025 |
| RIVA-AZITHROMYCIN (600 MG)Laboratoire Riva Inc. · Status since Jun 2024 | 02548895 | Approved | Laboratoire Riva Inc. | Jun 2024 |
| ACT AZITHROMYCIN (250 MG)Actavis Pharma Company · Status since Jun 2018 | 02255340 | Cancelled Post Market | Actavis Pharma Company | Jun 2018 |
| ACT AZITHROMYCIN (600 MG)Actavis Pharma Company · Status since Jun 2019 | 02256088 | Cancelled Post Market | Actavis Pharma Company | Jun 2019 |
| AVA-AZITHROMYCIN (100 MG)Avanstra Inc · Status since Aug 2014 | 02363372 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-AZITHROMYCIN (200 MG)Avanstra Inc · Status since Aug 2014 | 02363380 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AZASITE (1 %)Insite Vision Incorporated · Status since Apr 2018 | 02321661 | Cancelled (Unreturned Annual) | Insite Vision Incorporated | Apr 2018 |
| AZASITE (1 %)Inspire Pharmaceuticals Inc · Status since Aug 2022 | 02345498 | Cancelled Pre Market | Inspire Pharmaceuticals Inc | Aug 2022 |
| AZITHROMYCIN (100 MG)Pharmascience Inc. · Status since Jul 2025 | 02274388 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| AZITHROMYCIN (200 MG)Pharmascience Inc. · Status since Jul 2025 | 02274396 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| AZITHROMYCIN (600 MG)Sanis Health Inc. · Status since Aug 2014 | 02330911 | Cancelled Post Market | Sanis Health Inc. | Aug 2014 |
| AZITHROMYCIN (250 MG)4513347 Canada Inc. · Status since Apr 2018 | 02342030 | Cancelled (Unreturned Annual) | 4513347 Canada Inc. | Apr 2018 |
| AZITHROMYCIN (600 MG)4513347 Canada Inc. · Status since Apr 2018 | 02342049 | Cancelled (Unreturned Annual) | 4513347 Canada Inc. | Apr 2018 |
| AZITHROMYCIN (250 MG)Cobalt Pharmaceuticals Incorporated · Status since Sep 2017 | 02343347 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| AZITHROMYCIN (600 MG)Cobalt Pharmaceuticals Incorporated · Status since Sep 2017 | 02343355 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| AZITHROMYCIN (100 MG)Dominion Pharmacal · Status since Jun 2019 | 02418363 | Cancelled Pre Market | Dominion Pharmacal | Jun 2019 |
| AZITHROMYCIN (200 MG)Dominion Pharmacal · Status since Jun 2019 | 02418371 | Cancelled Pre Market | Dominion Pharmacal | Jun 2019 |
| AZITHROMYCIN (600 MG)Altamed Pharma · Status since Jun 2022 | 02477629 | Cancelled Pre Market | Altamed Pharma | Jun 2022 |
| AZITHROMYCIN FOR INJECTION (500 MG)Teva Canada Limited · Status since Nov 2017 | 02297566 | Cancelled Post Market | Teva Canada Limited | Nov 2017 |
| AZITHROMYCIN FOR INJECTION, USP (500 MG)Hospira Healthcare Corporation · Status since Sep 2018 | 02334844 | Cancelled Post Market | Hospira Healthcare Corporation | Sep 2018 |
| AZITHROMYCIN FOR INJECTION, USP (500 MG)Hospira Healthcare Corporation · Status since Dec 2018 | 02334976 | Cancelled Pre Market | Hospira Healthcare Corporation | Dec 2018 |
| AZITHROMYCIN FOR INJECTION, USP (500 MG)Mylan Pharmaceuticals Ulc · Status since Aug 2017 | 02385473 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Aug 2017 |
| GD-AZITHROMYCIN (250 MG)Genmed A Division Of Pfizer Canada Ulc · Status since Sep 2019 | 02274531 | Cancelled Post Market | Genmed A Division Of Pfizer Canada Ulc | Sep 2019 |
| GD-AZITHROMYCIN (100 MG)Genmed A Division Of Pfizer Canada Ulc · Status since Nov 2019 | 02274566 | Cancelled Post Market | Genmed A Division Of Pfizer Canada Ulc | Nov 2019 |
| GD-AZITHROMYCIN (200 MG)Genmed A Division Of Pfizer Canada Ulc · Status since Oct 2019 | 02274574 | Cancelled Post Market | Genmed A Division Of Pfizer Canada Ulc | Oct 2019 |
| PMS-AZITHROMYCIN (100 MG)Pharmascience Inc. · Status since Jul 2025 | 02418452 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| PMS-AZITHROMYCIN (200 MG)Pharmascience Inc. · Status since Jul 2025 | 02418460 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| RIVA AZITHROMYCIN (600 MG)Laboratoire Riva Inc. · Status since Jul 2013 | 02275317 | Cancelled Post Market | Laboratoire Riva Inc. | Jul 2013 |
| ZITHROMAX (250 MG)Pfizer Canada Ulc · Status since Jun 2025 | 02212021 | Cancelled Post Market | Pfizer Canada Ulc | Jun 2025 |
| ZITHROMAX (200 MG)Pfizer Canada Ulc · Status since Jun 2025 | 02223724 | Cancelled Post Market | Pfizer Canada Ulc | Jun 2025 |
| ZITHROMAX (500 MG)Pfizer Canada Ulc · Status since Dec 2014 | 02247748 | Cancelled Pre Market | Pfizer Canada Ulc | Dec 2014 |
| ZITHROMAX - PWS ORL 100MG/5ML (100 MG)Pfizer Canada Ulc · Status since Jun 2025 | 02223716 | Cancelled Post Market | Pfizer Canada Ulc | Jun 2025 |
| ZITHROMAX 600MG (600 MG)Pfizer Canada Ulc · Status since Jul 2025 | 02231143 | Cancelled Post Market | Pfizer Canada Ulc | Jul 2025 |
| ZITHROMAX CAP 250MG (250 MG)Pfizer Canada Ulc · Status since Jul 2000 | 02091291 | Cancelled Post Market | Pfizer Canada Ulc | Jul 2000 |
| ZITHROMAX FOR INTRAVENOUS INJECTION (500 MG)Pfizer Canada Ulc · Status since Jun 2025 | 02239952 | Cancelled Post Market | Pfizer Canada Ulc | Jun 2025 |
| ZMAX SR (2 G)Pfizer Canada Ulc · Status since Jul 2015 | 02354802 | Cancelled Post Market | Pfizer Canada Ulc | Jul 2015 |